Elanco Animal Health (ELAN) Net Income towards Common Stockholders Growth (5y) (2022 - 2026)
Powered by 
Analysis
Elanco Animal Health (ELAN) Net Income towards Common Stockholders Growth (5y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.73% |
| Mar 31, 2026 | 23.65% |
| Dec 31, 2025 | 3.08% |
| Sep 30, 2025 | 24.10% |
| Jun 30, 2025 | 17.16% |
| Mar 31, 2025 | 27.48% |
| Dec 31, 2024 | 3.38% |
| Sep 30, 2024 | 105.22% |
| Jun 30, 2024 | -27.68% |
| Mar 31, 2024 | 0.32% |
| Dec 31, 2023 | -60.34% |
| Sep 30, 2023 | -82.43% |
| Jun 30, 2023 | -9.08% |
| Mar 31, 2023 | 7.22% |
| Dec 31, 2022 | 19.68% |
| Sep 30, 2022 | -25.72% |